Xenon Pharmaceuticals Inc. Share Price
NASDAQ: XENE | Mid CapXenon Pharmaceuticals Inc. Stock Performance
Open $63.09 | Prev. Close $63.38 | Circuit Range N/A |
Day Range $63.09 - $64.17 | Year Range $32.90 - $72.50 | Volume 28,977 |
Average Traded $63.56 |
Xenon Pharmaceuticals Inc. Share Price Today
As of 11 August 2026, Xenon Pharmaceuticals Inc.'s share price is $64.25. The stock opened at $63.09, compared to its previous close of $63.38. During today's trading session, Xenon Pharmaceuticals Inc.'s share price traded between $63.09 and $64.17, with an average price of $63.63. Over the past 52 weeks, the stock has recorded a high of $72.50 and a low of $32.90. In terms of performance, Xenon Pharmaceuticals Inc.'s share price has risen by 48.55% over the last six months and is up 66.15% on a year-on-year basis.
Xenon Pharmaceuticals Inc. Share Price Chart
Xenon Pharmaceuticals Inc. Stock Fundamentals & Key Indicators
Market Cap $5.09B | PE Ratio (TTM) -14.74 | Dividend Yield N/A |
EPS (TTM) $-4.36 | Revenue (TTM) $7.50M | Return On Equity (TTM) -59.46% |
Profit Margin -4612.13% | Debt to Equity 0.07 | Quarterly Earnings Growth YoY -44.76% |
Xenon Pharmaceuticals Inc. Quarterly Profit & Loss
All figures in USD
Xenon Pharmaceuticals Inc. Annual Profit & Loss
All figures in USD
About Xenon Pharmaceuticals Inc.
Xenon Pharmaceuticals Inc., a neuroscience-focused biopharmaceutical company, engages in the discovery, development, and delivery of therapeutics to treat patients with neurological and psychiatric disorders in Canada. Its product candidates include Azetukalner, a selective Kv7 potassium channel opener in Phase 3 clinical development for the treatment of epilepsy, including focal onset seizures, and primary generalized tonic-clonic seizures, as well as neuropsychiatric disorders, such as major depressive disorder and bipolar depression. The company has a license and collaboration agreement with the Neurocrine Biosciences, Inc. for the development of NBI-921352, a Nav1.2/1.6 sodium channel inhibitor that is in Phase 1 clinical trials for the treatment of certain types of epilepsy. Xenon Pharmaceuticals Inc. was incorporated in 1996 and is headquartered in Burnaby, Canada.
Xenon Pharmaceuticals Inc. Historical Returns
| Month | Open | Close | Change % |
|---|---|---|---|
Aug 2026 | $63.33 | $63.44 | +1.20% |
Jul 2026 | $60.45 | $62.69 | +3.86% |
Jun 2026 | $53.90 | $60.36 | +10.29% |
May 2026 | $56.23 | $54.73 | -2.39% |
Apr 2026 | $58.58 | $56.07 | -3.55% |
Mar 2026 | $42.52 | $58.13 | +34.42% |
Feb 2026 | $41.22 | $43.25 | +5.36% |
Jan 2026 | $44.46 | $41.05 | -8.39% |
Dec 2025 | $44.33 | $44.81 | +0.27% |
Nov 2025 | $41.27 | $44.69 | +6.60% |
Oct 2025 | $40.14 | $41.92 | +4.43% |
Sep 2025 | $38.75 | $40.15 | +3.81% |
XENE Share Price FAQs
What is Xenon Pharmaceuticals Inc. share price today?
What is the 52 week high and 52 week low of Xenon Pharmaceuticals Inc. stock?
What is XENE's market capitalisation today?
What is XENE's net income for the last quarter?
What is the 5 year returns of XENE?
What is the high & low stock price of XENE today?
Can I buy XENE shares in India?